颈动脉支架置入术中栓塞保护装置与围术期结局的关联
基于VQI登记2015-2019年接受颈动脉支架置入术(CAS)的患者,比较使用与未使用栓塞保护装置(EPD)的围术期卒中和死亡结局。倾向评分匹配后,未使用EPD与院内死亡率升高相关(OR 2.40),30天死亡风险亦翻倍(HR 2.21),但卒中/TIA无显著差异。
要点
- 未使用EPD与CAS后院内死亡风险升高独立相关(OR 2.40)。
- 未使用EPD者30天死亡累积发生率4.3%,使用EPD者2.0%。
核心结论
- 与使用EPD相比,CAS未使用EPD与更高的院内死亡和30天死亡风险相关。
研究设计与样本
- 基于全国VQI登记数据库的回顾性队列研究,纳入2015-2019年接受CAS的患者,排除经颈动脉血运重建者。
- 采用倾向评分1:1匹配比较未尝试/失败EPD与成功使用任何EPD(远端或近端)的患者,并以逆倾向加权作为敏感性分析。
主要发现
- 共纳入19,451例患者,倾向评分1:1匹配后每组2,062例(年龄67.1±11.7岁;女性41.4%;白人87.1%)。
临床怎么用
- 真实世界证据提示CAS术中应使用EPD以降低围术期死亡风险,并可将EPD使用率纳入质量改进指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Carotid artery stenting (CAS) is frequently used in the management of carotid artery stenosis. Although the use of embolic protection devices (EPDs) is common, the association with lower mortality has been questioned. We aimed to assess the association between CAS with and without EPD and periprocedural stroke and mortality. METHODS: We included patients from the nationwide Vascular Quality Initiative registry who underwent CAS between 2015 and 2019. Patients undergoing transcarotid artery revascularization were excluded. Outcomes after CAS with either no EPD attempted or failed vs successful use of any EPD (distal or proximal) were analyzed in propensity score 1:1 matching cohort. Logistic regression was used to assess in-hospital mortality and stroke and transient ischemic attack outcomes (odds ratio [OR] with 95% confidence interval [CI]). Kaplan-Meier and Cox-proportional hazards regression were used to derive 30-day mortality cumulative incidence and risk. Analyses were replicated using inverse propensity weighting as a sensitivity analysis. RESULTS: A total of 19,451 patients were included, with 2062 per EPD group after 1:1 p propensity score matching (aged 67.1 ± 11.7 years; 41.4% female; 87.1% White). CAS without EPD was significantly associated with higher odds of in-hospital mortality (OR, 2.40; 95% CI, 1.50-3.85; P < .001), but not stroke/transient ischemia attack (OR, 1.26; 95% CI, 0.91-1.75; P = .160). The 30-day cumulative incidence and risk of death were twice as high in patients without vs with EPD (OR, 4.3% [95% CI, 3.5%-5.3%] vs OR, 2.0% [95% CI, 1.4%-2.7%]; P < .001; and hazard ratio, 2.21 [95% CI, 1.51-3.24]; P < .001). Sensitivity analysis revealed similar results. CONCLUSIONS: Not using an EPD was associated with higher in-hospital and 30-day mortality outcome in CAS when compared with EPD used. As the use of CAS increases, our real-world evidence highlights the risks of not using an EPD and the potential for including this metric as part of national quality improvement efforts for adequate CAS practices.
引用
- Callegari S, Romain G, Balasquide Odeh OS, et al. Periprocedural outcomes of embolic protection device use in carotid artery stenting. J Vasc Surg. 2025. PMID: 41077289. doi:10.1016/j.jvs.2025.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。